Li Wei, Shou Xinyi, Xiang Wenqing, He Lin, Li Lin, Fu Haidong, Mao Jianhua
Department of Clinical Laboratory, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Department of Nephrology, The Children' s Hospital, Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, China.
Front Immunol. 2022 Jan 31;12:801313. doi: 10.3389/fimmu.2021.801313. eCollection 2021.
This study aimed to evaluate gene expression patterns in urinary sediment samples of children with steroid-resistant nephrotic syndrome (SRNS).
The messenger RNA (mRNA) levels of 770 immune-related genes were detected using a NanoString nCounter platform. To verify the NanoString results, quantitative analysis of nine gene mRNAs was performed using real-time RT-PCR in more samples.
Firstly, compared with the steroid-sensitive nephrotic syndrome (SSNS) group (=3), significant changes were observed in the mRNA level of 70 genes, including MAP3K14, CYBA, SLC3A2, CREB-binding protein (CREBBP), CD68, forkhead box P1 (FOXP1), CD74, ITGB2, IFI30, and so forth, in the SRNS group (n=3). A total of 129 children with idiopathic nephrotic syndrome (INS), 15 with acute glomerulonephritis, and 6 with immunoglobulin A nephropathy (IgAN) were enrolled to verify the NanoString results. Compared with patients with IgAN, those with INS had significantly lower levels of FOXP1 (P=0.047) and higher levels of CREBBP (P=0.023). Among SSNS, the mRNA level of ITGB2 was significantly lower in the non-relapse group than in the non-frequent relapse and frequent-relapse groups (P=0.006). Compared with the SSNS group, CREBBP was significantly elevated in the SRNS group (P=0.02). Further, CYBA significantly decreased in the SRNS group (P=0.01). The area under the curve (AUC) for CREBBP and CYBA was 0.655 and 0.669, respectively. CREBBP had a sensitivity of 83.3% and a specificity of 49.4% and CYBA had a sensitivity of 58.3% and a specificity of 83.1% to rule out SSNS and SRNS. The diagnosis value was better for CREBBP+CYBA than for CREBBP or CYBA alone, indicating that the combination of CREBBP and CYBA was a more effective biomarker in predicting steroid resistance (AUC=0.666; sensitivity=63.9%; specificity=76.4%).
This study was novel in investigating the urinary sediment mRNA level in children with INS using high-throughput NanoString nCounter technology, and 70 genes that may relate to SRNS were found. The results revealed that the urinary sediment mRNA level of ITGB2 was significantly lower in the non-relapse group than in the non-frequent relapse and frequent-relapse groups. Meanwhile, CREBBP was significantly elevated and CYBA was significantly lowered in the SRNS group compared with the SSNS group.
本研究旨在评估激素抵抗型肾病综合征(SRNS)患儿尿沉渣样本中的基因表达模式。
使用NanoString nCounter平台检测770个免疫相关基因的信使核糖核酸(mRNA)水平。为验证NanoString的结果,在更多样本中使用实时逆转录聚合酶链反应(RT-PCR)对9个基因的mRNA进行定量分析。
首先,与激素敏感型肾病综合征(SSNS)组(n = 3)相比,SRNS组(n = 3)中70个基因的mRNA水平出现显著变化,包括丝裂原活化蛋白激酶激酶激酶14(MAP3K14)、细胞色素b-245α链(CYBA)、溶质载体家族3成员2(SLC3A2)、CREB结合蛋白(CREBBP)、CD68、叉头框蛋白P1(FOXP1)、CD74、整合素β2(ITGB2)、干扰素诱导蛋白30(IFI30)等。共纳入129例特发性肾病综合征(INS)患儿、15例急性肾小球肾炎患儿和6例免疫球蛋白A肾病(IgAN)患儿以验证NanoString的结果。与IgAN患者相比,INS患者的FOXP1水平显著降低(P = 0.047),CREBBP水平显著升高(P = 0.023)。在SSNS中,非复发组的ITGB2 mRNA水平显著低于非频繁复发组和频繁复发组(P = 0.006)。与SSNS组相比,SRNS组的CREBBP显著升高(P = 0.02)。此外,SRNS组的CYBA显著降低(P = 0.01)。CREBBP和CYBA的曲线下面积(AUC)分别为0.655和0.669。CREBBP排除SSNS和SRNS的敏感性为83.3%,特异性为49.4%;CYBA的敏感性为58.3%,特异性为83.1%。CREBBP + CYBA的诊断价值优于单独的CREBBP或CYBA,表明CREBBP和CYBA联合是预测激素抵抗更有效的生物标志物(AUC = 0.666;敏感性 = 63.9%;特异性 = 76.4%)。
本研究采用高通量NanoString nCounter技术研究INS患儿尿沉渣mRNA水平具有创新性,发现了70个可能与SRNS相关的基因。结果显示,非复发组的ITGB2尿沉渣mRNA水平显著低于非频繁复发组和频繁复发组。同时,与SSNS组相比,SRNS组的CREBBP显著升高,CYBA显著降低。